中国病毒学2023，Issue(2) ：285-295.

Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+cells in vivo

Hanyu Pan Xinyi Yang Jing Wang Huitong Liang Zhengtao Jiang Lin Zhao Yanan Wang Zhiming Liang Xiaoting Shen Qinru Lin Yue Liang Jinglong Yang Panpan Lu Yuqi Zhu Min Li Pengfei Wang Jianqing Xu Hongzhou Lu Huanzhang Zhu
中国病毒学2023，Issue(2) ：285-295.
✕
  • NETL
  • NSTL
  • 万方数据

Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+cells in vivo

Hanyu Pan 1Xinyi Yang 1Jing Wang 1Huitong Liang 1Zhengtao Jiang 1Lin Zhao 1Yanan Wang 1Zhiming Liang 1Xiaoting Shen 1Qinru Lin 1Yue Liang 1Jinglong Yang 1Panpan Lu 1Yuqi Zhu 1Min Li 1Pengfei Wang 2Jianqing Xu 3Hongzhou Lu 4Huanzhang Zhu1
扫码查看

作者信息

  • 1. State Key Laboratory of Genetic Engineering And Key Laboratory of Medical Molecular Virology of Ministry of Education/Health School of Life Sciences,Fudan University,Shanghai,200438,China
  • 2. Shanghai Institute of Infectious Disease and Biosecurity,School of Life Sciences,Fudan University,Shanghai,200438,China
  • 3. Department of Infectious Disease,Key Laboratory of Medical Molecular Virology of Ministry of Education/Health,School of Basic Medical Sciences and Shanghai Public Health Clinical Center,Fudan University,Shanghai,201508,China
  • 4. Scientific Research Center,Shanghai Public Health Clinical Center,Fudan University,Shanghai,201508,China;Department of Infectious Diseases and Immunology,Shanghai Public Health Clinical Center,Fudan University,Shanghai,201508,China;Department of Infectious Diseases and Nursing Research Institution,National Clinical Research Center for Infectious Diseases,The Third People's Hospital of Shenzhen,Shenzhen,518112,China
  • 折叠

Abstract

HIV-specific chimeric antigen receptor(CAR)T-cells have been developed to target HIV-1 infected CD4+T-cells that express HIV Env proteins.However,T cell exhaustion and the patient-specific autologous paradigm of CAR-T cell hurdled clinical applications.Here,we created HIV-specific CAR-T cells using human peripheral blood mononuclear cells and a 3BNC117-E27(3BE)CAR construct that enabled the expression of programmed cell death protein(PD-1)-blocking scFv E27 and the single-chain variable fragment of the HIV-1-specific broadly neutralizing antibody 3BNC117 to target native HIV Env.Compared with T cells expressing 3BNC117-CAR alone,3BE CAR-T cells showed greater cytotoxic activity against HIV Env+cells with stronger proliferation capability,higher killing efficiency,and enhanced cytokine secretion in the presence of HIV Env-expressing cells.Further-more,we manufactured TCR-deficient 3BE CAR-T cells through gene editing and demonstrated that these CAR-T cells could effectively kill HIV Env+cells in vivo without the occurrence of severe graft-versus-host disease(GvHD)in NSG mice.These data suggest that we have provided a feasible approach to the generation of"off-the-shelf'anti-HIV CAR-T cells in combination with PD-1 checkpoint blockade immunotherapy,which can be a powerful therapeutic candidate for the functional cure of HIV.

Key words

Anti-HIV CAR-T/PD-1 blocking/TCR disruption/Cellular immunotherapy

引用本文复制引用

基金项目

National Natural Science Foundation of China(81761128020)

National Natural Science Foundation of China(82041001)

National Grand Program on Key Infectious Diseases(2017ZX10202102-002)

出版年

2023
中国病毒学
中国科学院武汉病毒研究所，中国微生物学会

中国病毒学

CSTPCDCSCD北大核心
影响因子：0.393
ISSN：1674-0769
参考文献量58
段落导航相关论文